Director/PDMR Shareholding

29 Mar 2007 08:43

VASTox plc29 March 2007 VASTox plc ("VASTox" or "the Company") DIRECTOR SHAREHOLDING Chief Executive Officer buys shares Oxford, UK, 29 March 2007 - VASTox plc (AIM: VOX) has been informed that on 28March 2007 Dr Steven Lee, the Chief Executive Officer of the Company, purchased10,000 ordinary shares of 10 pence each in the Company ("Ordinary Share") at aprice of £1.29 per Ordinary Share. Following this purchase, Dr Lee has a total beneficial and non-beneficialholding of 158,148 Ordinary Shares, representing 0.3 per cent of the currentissued share capital of the Company. - ends - For more information, please contact: VASTox Steven Lee, PhD, Chief Executive Officer Tel: +44 (0)1235 443951 Darren Millington, Chief Financial Officer Citigate Dewe Rogerson Mark Swallow / David Dible / Valerie Auffray Tel: +44 (0)207 638 9571 About VASTox plc VASTox is a leading UK biotechnology company that discovers and developsproprietary new drugs. The Company's internal drug development programmes areunderpinned by its advanced chemistry and drug screening (chemical genomics)technology platforms, which it also provides on a collaborative orfee-for-service basis to the pharmaceutical industry. VASTox has a broad range of drug discovery programmes in the clinical,pre-clinical and discovery stages of development, which target serious diseaseswith a high unmet medical need. These therapeutic areas include neuro-disorders(neurodegenerative and neuromuscular), anti-infectives, ophthalmic diseases,oncology and regenerative medicines. VASTox's in-house drug development capabilities combine world-class expertise inboth medicinal and carbohydrate chemistry with high-volume, high-contentscreening using its proprietary zebrafish and fruitfly technologies (chemicalgenomics). These whole organism screens have the potential to dramaticallydecrease the time and cost of drug discovery and development by delivering datathat are highly predictive of the efficacy and toxicity of potential drugcompounds in humans. The company listed on the AIM market of the London Stock Exchange in October2004 - symbol: VOX Further information about the company is available at www.vastox.com. This information is provided by RNS The company news service from the London Stock Exchange